Results 11 to 20 of about 2,024,265 (255)

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation

Annals of Neurology, 2020
It is not known whether patients with atrial fibrillation (AF) with ischemic stroke despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how ongoing secondary prevention should be managed.
D. Seiffge, G. M. De Marchis, M. Koga, M. Paciaroni, D. Wilson, M. Cappellari, Kosmas Macha, G. Tsivgoulis, G. Ambler, S. Arihiro, L. Bonati, B. Bonetti, B. Kallmünzer, K. Muir, P. Bovi, H. Gensicke, M. Inoue, S. Schwab, S. Yaghi, Martin M. Brown, P. Lyrer, Masahito Takagi, Monica Acciarrese, H. Jager, A. Polymeris, K. Toyoda, M. Venti, C. Traenka, H. Yamagami, A. Alberti, S. Yoshimura, V. Caso, S. Engelter, D. Werring   +33 more
semanticscholar   +1 more source

Prevention of ischemic stroke in atrial fibrillation from the point of view of a neurologist. Standards and real clinical practice

Терапевтический архив, 2021
The article outlines aspects of the current state of the problem of the priority choice of an oral anticoagulant for indefinite prevention of stroke and systemic thromboembolism in patients with atrial fibrillation.
Marina Yu. Maksimova, Andrei V. Fonyakin, Liudmila A. Geraskina   +2 more
doaj   +1 more source

Impact of direct oral anticoagulant off‐label doses on clinical outcomes of atrial fibrillation patients: A systematic review

British Journal of Clinical Pharmacology, 2020
Worldwide observational studies are evidencing discordance between guidelines and real‐world practice regarding direct oral anticoagulant drug (DOAC) doses. This systematic review summarizes and evaluate DOACs use in real‐world practice.
Joana Santos, N. António, M. Rocha, A. Fortuna   +3 more
semanticscholar   +1 more source

Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.

PLoS ONE, 2020
BACKGROUND:Warfarin is an anticoagulant medication proven effective in the initial treatment and secondary prevention of venous thromboembolism. Anti-Xa direct oral anticoagulants are alternatives to warfarin; however there is limited data assessing ...
Thomas Hendriks, Scott McGregor, Shilpa Rakesh, Julie Robinson, Kwok M Ho, Ross Baker   +5 more
doaj   +1 more source

Trend of anticoagulant therapy in elderly patients with atrial fibrillation considering risks of cerebral infarction and bleeding

Scientific Reports, 2023
The introduction of direct oral anticoagulants (DOACs) has greatly changed the use of anticoagulant therapy in patients with non-valvular atrial fibrillation (Af).
Noriko Tsuji, Yoshimitsu Takahashi, Michi Sakai, Shosuke Ohtera, Junji Kaneyama, Kosai Cho, Genta Kato, Shigeru Ohtsuru, Takeo Nakayama   +8 more
doaj   +1 more source

The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis

Tzu Chi Medical Journal, 2023
Objectives: Anticoagulants have been used as therapeutic or prophylactic agents in COVID-19 and seem to be more beneficial. However, the advantage of oral anticoagulant (OAC) consumption before visit in lowering mortality in COVID-19 patients remains ...
Cornelia Ghea, Ardyan Wardhana, Alfredo Nugroho, Fika Humaeda Assilmi   +3 more
doaj   +1 more source

Direct oral anticoagulant: Review article

Journal of Family Medicine and Primary Care, 2022
Venous thromboembolism (VTE) and atrial fibrillation (AF) is a major burden on the health care system. The average occurrence of venous thromboembolism annually is around 108 per 100,000 person-year.
Abdulrahman Nasiri, Ahmed AlQahtani, Nora H Rayes, Rawan AlQahtani, Reem Alkharras, Hamad Alghethber   +5 more
doaj   +1 more source

The new, direct, target-specific oral anticoagulants

Journal of Applied Hematology, 2015
In recent years, numerous alternatives to VKAs have been developed, the first competitors to warfarin are the novel oral anticoagulants (NOAC) or better referred to as Direct Oral Anti-Coagulant (DOAC) or Target Specific Oral Anti-coagulant (TSOAC ...
Nevine A Kassim
doaj   +1 more source

Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience

Journal of Thrombosis and Haemostasis, 2020
Antiviral drugs are administered in patients with severe COVID‐19 respiratory syndrome, including those treated with direct oral anticoagulants (DOACs).
S. Testa, P. Prandoni, O. Paoletti, R. Morandini, M. Tala, C. Dellanoce, M. Giorgi-Pierfranceschi, M. Betti, G. Danzi, A. Pan, G. Palareti   +10 more
semanticscholar   +1 more source

Psychological Barriers in Long Term Non-Operative Treatment of Retroperitoneal Hematoma [PDF]

, 2015
The retroperitoneal hematoma can have, mainly, a traumatic etiology - blunt abdominal trauma (falls from height, road accidents, aggression of any kind, etc.), or open (incised wounds, puncture, penetration or gunshot wounds). Ruptured arterial aneurysms
Bobic, Simona, Carȃp, Alexandru, Constantin, Vlad Denis, Socea, Bogdan   +3 more
core   +4 more sources